Ledger. Australian venture funding, tracked

Associate Professor, University of Queensland

Dr Nathan Palpant

Coverage

Stories naming Dr Nathan Palpant. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Unnamed stage $23m

Biotech startup using funnel-web spider venom to treat heart attacks raises $23 million

Brisbane biotech Infensa Bioscience raised $23 million to develop a heart-attack and stroke treatment derived from funnel-web spider venom, after spinning out of the University of Queensland.

Startup Daily 4 Jul 2022 Infensa BioscienceMonash UniversityUniQuestUniversity of QueenslandVictor Chang Cardiac Research InstituteGlenn KingMark SmytheDr Nathan PalpantPeter MacdonaldRob Widdop

Also Cut Through Venture·SmartCompany

Something wrong? Tell us